SEC Info - Angiodynamics Inc - ‘10-Q’ for 8/31/15

SEC Info℠

Home

Help

Please Sign In

Angiodynamics Inc – ‘10-Q’ for 8/31/15 – ‘EX-32.2’

On: Thursday, 10/8/15, at 4:36pm ET · For: 8/31/15 · Accession #: 1275187-15-22 · File #: 0-50761

  As Of               Filer                 Filing    For·On·As Docs:Size

10/08/15  Angiodynamics Inc                 10-Q        8/31/15   69:5.1M

Quarterly Report — Form 10-Q — Sect. 13 / 15(d) – SEA’34
Filing Table of Contents

Document/Exhibit                   Description                      Pages   Size 

 1: 10-Q        Quarterly Report                                    HTML    371K 
 2: EX-31.1     Certification -- §302 - SOA'02                      HTML     26K 
 3: EX-31.2     Certification -- §302 - SOA'02                      HTML     26K 
 4: EX-32.1     Certification -- §906 - SOA'02                      HTML     21K 
 5: EX-32.2     Certification -- §906 - SOA'02                      HTML     21K 
46: R1          Document and Entity Information                     HTML     41K 
36: R2          Consolidated Statements of Income                   HTML     89K 
44: R3          Consolidated Statements of Comprehensive Income     HTML     50K 
48: R4          Consolidated Balance Sheets                         HTML    127K 
63: R5          Consolidated Balance Sheets (Parenthetical)         HTML     47K 
38: R6          Consolidated Statements of Cash Flows               HTML    103K 
43: R7          Consolidated Statement of Stockholders' Equity      HTML     70K 
32: R8          Consolidated Financial Statements                   HTML     30K 
25: R9          Inventories                                         HTML     32K 
64: R10         Goodwill and Intangible Assets                      HTML     75K 
50: R11         Accrued Liabilities                                 HTML     38K 
49: R12         Long Term Debt                                      HTML     30K 
54: R13         Income Taxes                                        HTML     59K 
55: R14         Share-Based Compensation                            HTML     30K 
53: R15         Earnings Per Share                                  HTML     33K 
56: R16         Segment and Geographic Information                  HTML     49K 
45: R17         Fair Value                                          HTML    138K 
47: R18         Marketable Securities                               HTML     53K 
52: R19         Commitments and Contingencies                       HTML     35K 
69: R20         Recently Issued Accounting Pronouncements           HTML     32K 
59: R21         Restructuring                                       HTML     24K 
40: R22         Inventories (Tables)                                HTML     31K 
51: R23         Goodwill and Intangible Assets (Tables)             HTML     70K 
42: R24         Accrued Liabilities (Tables)                        HTML     37K 
19: R25         Income Taxes (Tables)                               HTML     54K 
60: R26         Earnings Per Share (Tables)                         HTML     31K 
65: R27         Segment and Geographic Information (Tables)         HTML     44K 
28: R28         Fair Value (Tables)                                 HTML    131K 
27: R29         Marketable Securities (Tables)                      HTML     46K 
30: R30         Consolidated Financial Statements - Additional      HTML     70K 
                Information (Detail)                                             
31: R31         Acquisitions - Additional Information (Detail)      HTML     36K 
33: R32         Inventories - Schedule of Inventories (Detail)      HTML     30K 
18: R33         Goodwill and Intangible Assets - Additional         HTML     25K 
                Information (Detail)                                             
57: R34         Goodwill and Intangible Assets - Goodwill by        HTML     22K 
                Segment (Detail)                                                 
39: R35         Goodwill and Intangible Assets - Intangible Assets  HTML     57K 
                (Detail)                                                         
41: R36         Accrued Liabilities - Summary of Accrued            HTML     52K 
                Liabilities (Detail)                                             
22: R37         Long Term Debt - Additional Information (Detail)    HTML     77K 
68: R38         Income Taxes - Components of Income Tax             HTML     40K 
                Expense/(Benefit) (Detail)                                       
12: R39         Income Taxes - Additional Information (Detail)      HTML     31K 
34: R40         Income Taxes Net Operating Loss Carryforwards       HTML     45K 
                (Details)                                                        
62: R41         Share-Based Compensation (Details)                  HTML     29K 
21: R42         Earnings Per Share - Reconciliation of Basic to     HTML     28K 
                Diluted Weighted-Average Shares Outstanding                      
                (Detail)                                                         
26: R43         Segment and Geographic Information - Additional     HTML     22K 
                Information (Detail)                                             
29: R44         Segment and Geographic Information - Summary of     HTML     31K 
                Net Sales by Product Category (Detail)                           
37: R45         Segment and Geographic Information - Summary of     HTML     31K 
                Net Sales by Geographic Area (Detail)                            
17: R46         Fair Value - Additional Information (Detail)        HTML     21K 
24: R47         Fair Value - Fair Value of Assets and Liabilities   HTML     67K 
                Measured on a Recurring Basis (Detail)                           
14: R48         Fair Value - Fair Value Measurements Using          HTML     41K 
                Significant Unobservable Inputs (Detail)                         
61: R49         Fair Value - Summary Showing the Recurring Fair     HTML     53K 
                Value Measurements of the Contingent Consideration               
                Liability (Detail)                                               
20: R50         Fair Value - Summary Showing Reconciliation of the  HTML     25K 
                Contingent Payments (Detail)                                     
58: R51         Marketable Securities - Additional Information      HTML     23K 
                (Detail)                                                         
23: R52         Marketable Securities - Marketable Securities       HTML     34K 
                (Detail)                                                         
35: R53         Commitments and Continfencies - Additional          HTML     35K 
                Information (Detail)                                             
13: R54         Restructuring - Additional Information (Detail)     HTML     26K 
16: R55         Immaterial Corrections (Details)                    HTML    111K 
67: XML         IDEA XML File -- Filing Summary                      XML    120K 
15: EXCEL       IDEA Workbook of Financial Reports                  XLSX     63K 
 6: EX-101.INS  XBRL Instance -- ango-20150831                       XML   1.26M 
 8: EX-101.CAL  XBRL Calculations -- ango-20150831_cal               XML    187K 
 9: EX-101.DEF  XBRL Definitions -- ango-20150831_def                XML    507K 
10: EX-101.LAB  XBRL Labels -- ango-20150831_lab                     XML   1.25M 
11: EX-101.PRE  XBRL Presentations -- ango-20150831_pre              XML    786K 
 7: EX-101.SCH  XBRL Schema -- ango-20150831                         XSD    144K 
66: ZIP         XBRL Zipped Folder -- 0001275187-15-000022-xbrl      Zip    167K

‘EX-32.2’ — Certification — §906 – SOA’02

This Exhibit is an HTML Document rendered as filed. [ Alternative Formats ]

<! C: C:

Exhibit

Exhibit 32.2

CERTIFICATION OF CHIEF FINANCIAL OFFICER PURSUANT TO TITLE 18,

UNITED STATES CODE, SECTION 1350, AS ADOPTED PURSUANT TO

SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

I, Mark T. Frost Executive Vice President and Chief Financial Officer of ANGIODYNAMICS, Inc. (the "Company"), certify, pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, 18 U.S.C. Section 1350, that, to the best of my knowledge:



1.		the quarterly report on Form 10-Q of the Company for the fiscal quarter ended August 31, 2015 (the "Report") fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934 (15 U.S.C. 78m or 78o(d)); and
2.		the information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.

Date: October 8, 2015



/ s / Mark T. Frost
Mark T. Frost, Executive Vice President and Chief Financial Officer

Dates Referenced Herein and Documents Incorporated by Reference

This ‘10-Q’ Filing	Date	Other Filings

Filed on:	10/8/15	8-K
For Period end:	8/31/15
		List all Filings

↑Top

Filing Submission 0001275187-15-000022 – Alternative Formats (Word / Rich Text, HTML, Plain Text, et al.)